Nanostructure initiator mass spectrometry: Tissue imaging and direct biofluid analysis

  • Oscar Yanes
  • , Hin Koon Woo
  • , Trent R. Northen
  • , Stacey R. Oppenheimer
  • , Leah Shriver
  • , Jon Apon
  • , Mayra N. Estrada
  • , Michael J. Potchoiba
  • , Rick Steenwyk
  • , Marianne Manchester
  • , Gary Siuzdak

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Abstract

Nanostructure initiator mass spectrometry (NIMS) is a recently introduced matrix-free desorption/ionization platform that requires minimal sample preparation. Its application to xenobiotics and endogenous metabolites in tissues is demonstrated, where clozapine and N-desm-ethylclozapine were observed from mouse and rat brain sections. It has also been applied to direct biofluid analysis where ketamine and norketamine were observed from plasma and urine. Detection of xenobiotics from biofluids was made even more effective using a novel NIMS on-surface extraction method taking advantage of the hydrophobic nature of the initiator. Linear response and limit of detection were also evaluated for xenobiotics such as methamphetamine, codeine, alprazolam, and morphine, revealing that NIMS can be used for quantitative analysis. Overall, our results demonstrate the capacity of NIMS to perform sensitive, simple, and rapid analyses from highly complex biological tissues and fluids.

Original languageEnglish
Pages (from-to)2969-2975
Number of pages7
JournalAnalytical Chemistry
Volume81
Issue number8
DOIs
StatePublished - Apr 15 2009

Fingerprint

Dive into the research topics of 'Nanostructure initiator mass spectrometry: Tissue imaging and direct biofluid analysis'. Together they form a unique fingerprint.

Cite this